Works matching IS 17568722 AND DT 2025 AND VI 18 AND IP 1

Results: 56
    1
    2
    3
    4
    5
    6
    7

    A multicenter, open-label, single-arm, phase Ib clinical trial of HH2853 treatment in patients with relapsed and/or refractory peripheral T-cell lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01697-z
    By:
    • Hong, Huangming;
    • Chen, Zegeng;
    • Zhang, Mingzhi;
    • Peng, Zhigang;
    • Shen, Jianzhen;
    • Shuang, Yuerong;
    • Zhou, Hui;
    • Guo, Hongqiang;
    • Huang, He;
    • Li, Fei;
    • Qian, Zhengzi;
    • Liu, Lihong;
    • Wang, Liang;
    • Yang, Wei;
    • Zhang, Liling;
    • He, Pengcheng;
    • Qian, Shen;
    • Li, Fugen;
    • Li, Meng;
    • Lin, Tongyu
    Publication type:
    Article
    8

    PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01700-7
    By:
    • Zeremski, Vanja;
    • Haage, Tobias R.;
    • Witte, Hanno M.;
    • Adolph, Louisa;
    • Beer, Sina A.;
    • Behre, Gerhard;
    • Jacobs, Benedikt;
    • Kahl, Christoph;
    • Lalayanni, Chrysavgi;
    • Panse, Jens;
    • Papageorgiou, Sotirios;
    • Siakantaris, Marina P.;
    • Schneider, Jessica;
    • Schnetzke, Ulf;
    • Schulz, Alexander;
    • Vassilakopoulos, Theodoros P.;
    • Walter, Jeanette;
    • Mougiakakos, Dimitrios
    Publication type:
    Article
    9
    10

    KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01696-0
    By:
    • Yousef, Mahmoud;
    • Yousef, Abdelrahman;
    • Hurd, Mark W.;
    • Pillai, Ashwathy;
    • Chowdhury, Saikat;
    • Snyder, Rebecca;
    • Knafl, Mark;
    • Lewis, Ryan L.;
    • Roy, Paul M.;
    • Fanaeian, Mohammad;
    • Albarouki, Sali;
    • Castelnovo, Luca F.;
    • Peterson, Jennifer;
    • Smaglo, Brandon G.;
    • Wolff, Robert A.;
    • Pant, Shubham;
    • Willis, Jason;
    • Huey, Ryan;
    • Overman, Michael;
    • Tzeng, Ching-Wei
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.

    Published in:
    2025
    By:
    • Berneman, Zwi N.;
    • De Laere, Maxime;
    • Germonpré, Paul;
    • Huizing, Manon T.;
    • Willemen, Yannick;
    • Lion, Eva;
    • De Reu, Hans;
    • Van den Bossche, Jolien;
    • Van den Brande, Jan;
    • Specenier, Pol;
    • Altintas, Sevilay;
    • van Dam, Peter A.;
    • Cools, Nathalie;
    • Nijs, Griet;
    • Stein, Barbara;
    • Caluwaerts, Kim;
    • Snoeckx, Annemiek;
    • de Beeck, Bart Op;
    • Saevels, Kirsten;
    • Rutsaert, Lynn
    Publication type:
    Correction Notice
    22
    23
    24
    25
    26
    27
    28

    Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01676-4
    By:
    • Umyarova, Elvira;
    • Pei, Charles;
    • Pellegrino, William;
    • Zhao, Qiuhong;
    • Sharma, Nidhi;
    • Benson, Don;
    • Cottini, Francesca;
    • Bezerra, Evandro;
    • Brammer, Jonathan;
    • Bumma, Naresh;
    • Choe, Hannah;
    • Denlinger, Nathan;
    • Devarakonda, Srinivas;
    • Khan, Abdullah;
    • Penza, Sam;
    • Rosko, Ashley;
    • Vasu, Sumithira;
    • Wall, Sarah;
    • Alinari, Lapo;
    • Baiocchi, Robert
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37

    IL-15: from discovery to FDA approval.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01664-8
    By:
    • Li, Zihai;
    • Wrangle, John;
    • He, Kai;
    • Sprent, Jonathan;
    • Rubinstein, Mark P.
    Publication type:
    Article
    38
    39

    First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01669-3
    By:
    • Shapiro, Roman M.;
    • Sheffer, Michal;
    • Booker, Matthew A.;
    • Tolstorukov, Michael Y.;
    • Birch, Grace C.;
    • Sade-Feldman, Moshe;
    • Fang, Jacy;
    • Li, Shuqiang;
    • Lu, Wesley;
    • Ansuinelli, Michela;
    • Dulery, Remy;
    • Tarannum, Mubin;
    • Baginska, Joanna;
    • Dwivedi, Nishant;
    • Kothari, Ashish;
    • Penter, Livius;
    • Abdulhamid, Yasmin Z.;
    • Kaplan, Isabel E.;
    • Khanhlinh, Dinh;
    • Uppaluri, Ravindra
    Publication type:
    Article
    40
    41

    Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01666-6
    By:
    • Chen, Gang;
    • Sun, Dong-Chen;
    • Ba, Yi;
    • Zhang, Ya-Xiong;
    • Zhou, Ting;
    • Zhao, Yuan-Yuan;
    • Zhao, Hong-Yun;
    • Fang, Wen-Feng;
    • Huang, Yan;
    • Wang, Zhen;
    • Deng, Chao;
    • Hu, De-Sheng;
    • Wang, Wei;
    • Lin, Jin-Guan;
    • Li, Gui-Ling;
    • Luo, Su-Xia;
    • Fu, Zhi-Chao;
    • Zhu, Hai-Sheng;
    • Wang, Hui-Li;
    • Cai, Sheng-Li
    Publication type:
    Article
    42
    43
    44
    45

    Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

    Published in:
    2025
    By:
    • Hose, Dirk;
    • Ray, Seemun;
    • Rößler, Sina;
    • Thormann, Ulrich;
    • Schnettler, Reinhard;
    • de Veirman, Kim;
    • Khassawna, Thaqif El;
    • Heiss, Christian;
    • Hild, Anne;
    • Zahner, Daniel;
    • Alagboso, Francisca;
    • Henss, Anja;
    • Beck, Susanne;
    • Emde-Rajaratnam, Martina;
    • Burhenne, Jürgen;
    • Bamberger, Juliane;
    • Menu, Eline;
    • de Bruyne, Elke;
    • Gelinsky, Michael;
    • Kampschulte, Marian
    Publication type:
    Correction Notice
    46

    WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01661-x
    By:
    • Berneman, Zwi N.;
    • De Laere, Maxime;
    • Germonpré, Paul;
    • Huizing, Manon T.;
    • Willemen, Yannick;
    • Lion, Eva;
    • De Reu, Hans;
    • Van den Bossche, Jolien;
    • Van den Brande, Jan;
    • Specenier, Pol;
    • Altintas, Sevilay;
    • van Dam, Peter A.;
    • Cools, Nathalie;
    • Nijs, Griet;
    • Stein, Barbara;
    • Caluwaerts, Kim;
    • Snoeckx, Annemiek;
    • Op de Beeck, Bart;
    • Saevels, Kirsten;
    • Rutsaert, Lynn
    Publication type:
    Article
    47
    48

    Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-024-01645-3
    By:
    • Dona, Ada Alice;
    • Tandoh, Theophilus;
    • Nigam, Lokesh;
    • Singer, Mahmoud;
    • Caserta, Enrico;
    • Murtadha, Mariam;
    • Zhu, Yinghui;
    • Moloudizargari, Milad;
    • Sharma, Preeti;
    • Napolitano, Ottavio;
    • Winchester, Janet;
    • Chowdhury, Arnab;
    • Pozhitkov, Alex;
    • Sanchez, James F.;
    • Vahed, Hawa;
    • Marcucci, Guido;
    • Coffey, Matt;
    • Nuovo, Gerard;
    • Sborov, Douglas W.;
    • Pichiorri, Flavia
    Publication type:
    Article
    49

    Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-024-01658-y
    By:
    • Chowdhury, Sayan Mullick;
    • Bhatta, Subodh;
    • Voorhees, Timothy J.;
    • Annunzio, Kaitlin;
    • Bond, David A.;
    • Sawalha, Yazeed;
    • Sigmund, Audrey;
    • Hanel, Walter;
    • Sehgal, Lalit;
    • Alinari, Lapo;
    • Baiocchi, Robert;
    • Maddocks, Kami;
    • Christian, Beth;
    • Jones, Dan;
    • Epperla, Narendranath
    Publication type:
    Article
    50

    Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults.

    Published in:
    Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-024-01659-x
    By:
    • Breidenbach, Maike;
    • Bader, Peter;
    • Attarbaschi, Andishe;
    • Rossig, Claudia;
    • Meisel, Roland;
    • Metzler, Markus;
    • Subklewe, Marion;
    • Mueller, Fabian;
    • Schlegel, Paul-Gerhardt;
    • Teichert von Lüttichau, Irene;
    • Bourquin, Jean-Pierre;
    • Escherich, Gabriele;
    • Cario, Gunnar;
    • Lang, Peter;
    • Coffey, Ramona;
    • von Stackelberg, Arend;
    • Willier, Semjon;
    • Strahm, Brigitte;
    • Peters, Christina;
    • Feuchtinger, Tobias
    Publication type:
    Article